{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:27:48Z","timestamp":1784309268442,"version":"3.55.0"},"reference-count":52,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T00:00:00Z","timestamp":1445990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Mass drug administration using praziquantel is the backbone of the current strategy for the control of schistosomiasis. As the theoretical plans have moved into practical application, certain challenges with this approach have surfaced, and it is likely that annual mass drug administration alone may not be sufficient to achieve program goals. However, mass drug administration is still the only available intervention that can be readily used in the wide variety of settings where schistosomiasis is endemic. The task then becomes how to improve this approach and identify what adjuncts to mass drug administration are effective, as programs move from morbidity control to elimination goals. Other aspects worthy of consideration include how best to employ new diagnostic tools to more easily identify where treatment is needed, and new formulations of praziquantel to extend the availability of treatment to all age groups. The aim of this review is to highlight both areas of challenge and of opportunity to improve the public health impact of schistosomiasis control programs.<\/ns4:p>","DOI":"10.12688\/f1000research.6826.1","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T05:50:08Z","timestamp":1446011408000},"page":"1157","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Early lessons from schistosomiasis mass drug administration programs"],"prefix":"10.12688","volume":"4","author":[{"given":"W. Evan","family":"Secor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2015,10,28]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"677-80","DOI":"10.4155\/fmc.15.16","article-title":"Praziquantel: do we need another antischistosoma treatment?","volume":"7","author":"A Fenwick","year":"2015","journal-title":"Future Med Chem."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1371\/journal.pntd.0000897","article-title":"Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study.","volume":"4","author":"M French","year":"2010","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-3305-7-14","article-title":"Schistosoma mansoni infection after three years of mass drug administration in Sierra Leone.","volume":"7","author":"S Sesay","year":"2014","journal-title":"Parasit Vectors."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"e3221","DOI":"10.1371\/journal.pntd.0003221","article-title":"No apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in Mwea, central Kenya, a heavy transmission area.","volume":"8","author":"A Lelo","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"e0123673","DOI":"10.1371\/journal.pone.0123673","article-title":"Uptake of mass drug administration programme for schistosomiasis control in Koome Islands, Central Uganda.","volume":"10","author":"D Tuhebwe","year":"2015","journal-title":"PLoS One."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"2220-1","DOI":"10.1016\/S0140-6736(14)61417-3","article-title":"An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration.","volume":"385","author":"A Ross","year":"2015","journal-title":"Lancet."},{"key":"ref-7","first-page":"25-32","article-title":"Schistosomiasis: number of people treated worldwide in 2013.","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"982-8","DOI":"10.4269\/ajtmh.14-0136","article-title":"The effect of a health communication campaign on compliance with mass drug administration for schistosomiasis control in western Kenya--the SCORE project.","volume":"91","author":"M Omedo","year":"2014","journal-title":"Am J Trop Med Hyg."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"322-8","DOI":"10.4269\/ajtmh.13-0361","article-title":"Assessment of quality of life as a tool for measuring morbidity due to Schistosoma mansoni infection and the impact of treatment.","volume":"90","author":"K Won","year":"2014","journal-title":"Am J Trop Med Hyg."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"e3286","DOI":"10.1371\/journal.pntd.0003286","article-title":"Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials.","volume":"8","author":"J Zwang","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"e63438","DOI":"10.1371\/journal.pone.0063438","article-title":"Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study.","volume":"8","author":"S Muhumuza","year":"2013","journal-title":"PLoS One."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"197-205","DOI":"10.1016\/j.pt.2013.02.001","article-title":"Schistosomiasis in African infants and preschool children: let them now be treated!","volume":"29","author":"J Stothard","year":"2013","journal-title":"Trends Parasitol."},{"key":"ref-13","article-title":"Helminth Control in School-Age Children: A Guide for Managers of Control Programmes","year":"2011"},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"e1384","DOI":"10.1371\/journal.pntd.0001384","article-title":"Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of C\u00f4te d'Ivoire.","volume":"5","author":"J Coulibaly","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"e1758","DOI":"10.1371\/journal.pntd.0001758","article-title":"Evaluation of circulating cathodic antigen (CCA) urine-tests for diagnosis of Schistosoma mansoni infection in Cameroon.","volume":"6","author":"L Tchuem Tchuent\u00e9","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"619-22","DOI":"10.1016\/j.trstmh.2012.06.010","article-title":"Notes on the use of urine-CCA dipsticks for detection of intestinal schistosomiasis in preschool children.","volume":"106","author":"A Navaratnam","year":"2012","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"426-32","DOI":"10.4269\/ajtmh.12-0639","article-title":"A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni.","volume":"88","author":"D Colley","year":"2013","journal-title":"Am J Trop Med Hyg."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"1029-35","DOI":"10.1111\/tmi.12117","article-title":"Evaluation of urine-circulating cathodic antigen (Urine-CCA) cassette test for the detection of Schistosoma mansoni infection in areas of moderate prevalence in Ethiopia.","volume":"18","author":"B Erko","year":"2013","journal-title":"Trop Med Int Health."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"50-7","DOI":"10.1016\/j.actatropica.2014.04.001","article-title":"Evaluation of circulating cathodic antigen (CCA) urine-cassette assay as a survey tool for Schistosoma mansoni in different transmission settings within Bugiri District, Uganda.","volume":"136","author":"M Adriko","year":"2014","journal-title":"Acta Trop."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"1227-32","DOI":"10.4269\/ajtmh.14-0643","article-title":"Evaluation of point-of-contact circulating cathodic antigen assays for the detection of Schistosoma mansoni infection in low-, moderate-, and high-prevalence schools in western Kenya.","volume":"92","author":"K Foo","year":"2015","journal-title":"Am J Trop Med Hyg."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"1233-9","DOI":"10.4269\/ajtmh.14-0644","article-title":"Cost analysis of tests for the detection of Schistosoma mansoni infection in children in western Kenya.","volume":"92","author":"C Worrell","year":"2015","journal-title":"Am J Trop Med Hyg."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"198-203","DOI":"10.1016\/j.actatropica.2014.09.003","article-title":"Evaluation of banked urine samples for the detection of circulating anodic and cathodic antigens in Schistosoma mekongi and S. japonicum infections: a proof-of-concept study.","volume":"141","author":"G van Dam","year":"2015","journal-title":"Acta Trop."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"1841-55","DOI":"10.1017\/S0031182014000626","article-title":"Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels.","volume":"141","author":"P Corstjens","year":"2014","journal-title":"Parasitology."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"e0003752","DOI":"10.1371\/journal.pntd.0003752","article-title":"Sensitivity and Specificity of a Urine Circulating Anodic Antigen Test for the Diagnosis of Schistosoma haematobium in Low Endemic Settings.","volume":"9","author":"S Knopp","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"e1746","DOI":"10.1371\/journal.pntd.0001746","article-title":"A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles.","volume":"6","author":"A Solomon","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"797-800","DOI":"10.1016\/j.ijpara.2012.07.002","article-title":"Development of a new platform for neglected tropical disease surveillance.","volume":"42","author":"P Lammie","year":"2012","journal-title":"Int J Parasitol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"489-97","DOI":"10.1016\/S1473-3099(14)70067-2","article-title":"Serodiagnosis of Schistosoma japonicum infection: genome-wide identification of a protein marker, and assessment of its diagnostic validity in a field study in China.","volume":"14","author":"X Xu","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"e0003959","DOI":"10.1371\/journal.pntd.0003959","article-title":"Is PCR the Next Reference Standard for the Diagnosis of Schistosoma in stool? A Comparison with Microscopy in Senegal and Kenya.","volume":"9","author":"L Meurs","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-29","article-title":"Schistosomiasis: progress report 2001\u20132011 and strategic plan 2012\u20132020","year":"2013"},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"e3319","DOI":"10.1371\/journal.pntd.0003319","article-title":"Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.","volume":"8","author":"K Ramaiah","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"e3113","DOI":"10.1371\/journal.pntd.0003113","article-title":"Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.","volume":"8","author":"D Evans","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"412-22","DOI":"10.1016\/j.actatropica.2011.04.010","article-title":"From morbidity control to transmission control: time to change tactics against helminths on Unguja Island, Zanzibar.","volume":"128","author":"S Knopp","year":"2013","journal-title":"Acta Trop."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1756-3305-7-74","article-title":"Once a year school-based deworming with praziquantel and albendazole combination may not be adequate for control of urogenital schistosomiasis and hookworm infection in Matuga District, Kwale County, Kenya.","volume":"7","author":"S Njenga","year":"2014","journal-title":"Parasit Vectors."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"283-9","DOI":"10.1093\/infdis\/jiu416","article-title":"Can mass drug administration lead to the sustainable control of schistosomiasis?","volume":"211","author":"A Ross","year":"2015","journal-title":"J Infect Dis."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2015.00273","article-title":"Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model.","volume":"6","author":"C Carvalho-Queiroz","year":"2015","journal-title":"Front Immunol."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"e0003730","DOI":"10.1371\/journal.pntd.0003730","article-title":"Suppression of the Insulin Receptors in Adult Schistosoma japonicum Impacts on Parasite Growth and Development: Further Evidence of Vaccine Potential.","volume":"9","author":"H You","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"e2337","DOI":"10.1371\/journal.pntd.0002337","article-title":"The schistosome oesophageal gland: initiator of blood processing.","volume":"7","author":"X Li","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"246-54","DOI":"10.1179\/2047773214Y.0000000149","article-title":"Water-based interventions for schistosomiasis control.","volume":"108","author":"W Evan Secor","year":"2014","journal-title":"Pathog Glob Health."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13071-015-0766-9","article-title":"The roles of water, sanitation and hygiene in reducing schistosomiasis: a review.","volume":"8","author":"J Grimes","year":"2015","journal-title":"Parasit Vectors."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"e3060","DOI":"10.1371\/journal.pntd.0003060","article-title":"The prawn Macrobrachium vollenhovenii in the Senegal River basin: towards sustainable restocking of all-male populations for biological control of schistosomiasis.","volume":"8","author":"A Savaya Alkalay","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"9650-5","DOI":"10.1073\/pnas.1502651112","article-title":"Reduced transmission of human schistosomiasis after restoration of a native river prawn that preys on the snail intermediate host.","volume":"112","author":"S Sokolow","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"139-46","DOI":"10.1016\/S0001-706X(02)00045-1","article-title":"The global epidemiological situation of schistosomiasis and new approaches to control and research.","volume":"82","author":"D Engels","year":"2002","journal-title":"Acta Trop."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"e0003504","DOI":"10.1371\/journal.pntd.0003504","article-title":"It's time to dispel the myth of \"asymptomatic\" schistosomiasis.","volume":"9","author":"C King","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-44","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.15-0467","article-title":"Predictive Value of School-Aged Children's Schistosomiasis Prevalence and Egg Intensity for Other Age Groups in Western Kenya.","author":"P Mwinzi","year":"2015","journal-title":"Am J Trop Med Hyg."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"4207-15","DOI":"10.1128\/AEM.00750-15","article-title":"Real-time PCR and sequencing assays for rapid detection and identification of avian schistosomes in environmental samples.","volume":"81","author":"N Jothikumar","year":"2015","journal-title":"Appl Environ Microbiol."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fpubh.2015.00048","article-title":"Additional Evaluation of the Point-of-Contact Circulating Cathodic Antigen Assay for Schistosoma mansoni Infection.","volume":"3","author":"P Mwinzi","year":"2015","journal-title":"Front Public Health."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"e3139","DOI":"10.1371\/journal.pntd.0003139","article-title":"Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment.","volume":"8","author":"P Lamberton","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"e1321","DOI":"10.1371\/journal.pntd.0001321","article-title":"Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review.","volume":"5","author":"C King","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"23-9","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: praziquantel forever?","volume":"195","author":"D Cioli","year":"2014","journal-title":"Mol Biochem Parasitol."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"707-11","DOI":"10.4155\/fmc.14.164","article-title":"Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis.","volume":"7","author":"E Lee","year":"2015","journal-title":"Future Med Chem."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"727-35","DOI":"10.4155\/fmc.15.26","article-title":"Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline.","volume":"7","author":"R Ramamoorthi","year":"2015","journal-title":"Future Med Chem."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"737-52","DOI":"10.4155\/fmc.15.31","article-title":"Re-positioning protein-kinase inhibitors against schistosomiasis.","volume":"7","author":"V Gelmedin","year":"2015","journal-title":"Future Med Chem."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/4-1157\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/4-1157\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/4-1157\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T09:48:22Z","timestamp":1553248102000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/4-1157\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,28]]},"references-count":52,"URL":"https:\/\/doi.org\/10.12688\/f1000research.6826.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.7340.r10946","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.7340.r10945","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.7340.r10947","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.7340.r10946","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.7340.r10947","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.7340.r10945","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,28]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/4-1157\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.7340.r10945, Don McManus, Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia, 28 Oct 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-1157\/v1#referee-response-10945","order":0,"name":"referee-response-10945","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.7340.r10946, Alan Fenwick, Faculty of Medicine, School of Public Health, Imperial College London, London, UK, 28 Oct 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-1157\/v1#referee-response-10946","order":1,"name":"referee-response-10946","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.7340.r10947, David Rollinson, Wolfson Wellcome Biomedical Laboratories, Life Sciences, Natural History Museum, London, UK, 28 Oct 2015, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/4-1157\/v1#referee-response-10947","order":2,"name":"referee-response-10947","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}